Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Xenetic Biosciences is a biopharmaceutical company developing innovative immuno-oncology therapies, focusing on targeting tumor microenvironments with proprietary DNase technology. Its core activities include advancing drug candidates for solid tumors like pancreatic and colorectal cancers, leveraging collaborations and licensing. The company emphasizes research, strategic partnerships, and patent protection to create next-generation biologics addressing unmet medical needs in cancer treatment.
This description was generated via AI from an annual report. Updated about 1 year ago.